Arterial tonometry
Diagnostic TestArterial transcutaneous tonometry
NCT Number: NCT06309511
The aim of the research is to evaluate the Subendocardial Viability Ratio (SEVR) in hypertensive patients, using non-invasive arterial tonometry, and to establish the influencing factors and the possibility of predicting cardiovascular morbidity and mortality in arterial hypertension.
The SEVR will be evaluated on all patients belonging to the Arterial Hypertension Centers undergoing non-invasive arterial tonometry.
The SEVR is calculated on the morphology of the central pressure wave as the ratio between the DPTI (diastolic pressure-time index), i.e. the area between the carotid pressure curve and the ventricular pressure curve during the diastolic phase, and the SPTI ( systolic pressure-time index), i.e. the area under the carotid pressure curve during the systolic phase.
The SEVR will be correlated with the anthropometric and pathology variables which will be collected in an appropriate database.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Centro di Prevenzione e Cura dell'Ipertensione Arteriosa "Alessandro Filippi", Mascalucia, Catania, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Arterial transcutaneous tonometry
Time frame: At recruitment, at 1 year, 2 years, 3 years and 4 years of follow-up
Assessment of subendocardial viability ratio (SEVR)
Contact information is provided by the study sponsor or research team.
Istituto Auxologico Italiano
Other
Acronym: SEVR-HT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06984211
Cardiovascular Diseases, Diabetes
Stockholm, Sweden
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT05690009
Albuminuria, Arrhythmias, Cardiac
Moscow, Russia
View Trial Details